Pidrman V, Krpálek P
Psychiatrická klinika LF UK Hradec Králové.
Cesk Psychiatr. 1992 Jun;88(2):106-12.
In a 21-day investigation in 15 patients with depression the authors investigated the incidence of undesirable side-effects in relation to plasma amitriptyline levels. The authors found the upper range of plasma concentrations when the patient's risk is minimal as regards serious undesirable complications. This upper limit is 350 micrograms/l; as compared with previous work, they consider amitriptyline levels from 150 to 350 350 micrograms/l safe and therapeutically effective. The authors consider investigation of plasma levels indicated in risk patients and in patients with an inadequate response to treatment.
在一项针对15名抑郁症患者的为期21天的调查中,作者研究了与血浆阿米替林水平相关的不良副作用的发生率。作者发现,当患者发生严重不良并发症的风险最低时,血浆浓度的上限。这个上限是350微克/升;与之前的研究相比,他们认为血浆阿米替林水平在150至350微克/升之间是安全且有治疗效果的。作者认为对有风险的患者以及对治疗反应不足的患者进行血浆水平检测是有必要的。